Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections

Pharmacol Res. 2018 Nov:137:259-269. doi: 10.1016/j.phrs.2018.09.022. Epub 2018 Oct 10.

Abstract

Currently, the numbers of patients with cancer, fibrosis, diabetes, chronic kidney disease, stroke and osteoporosis are increasing fast and fast. It's critical necessary to discovery lead compounds for new drug development. Dioscin, one active compound in some medicinal plants, has anti-inflammation, immunoregulation, hypolipidemic, anti-viral, anti-fungal and anti-allergic effects. In recent years, dioscin has reached more and more attention with its potent effects to treat liver, kidney, brain, stomach and intestine damages, and metabolic diseases including diabetes, osteoporosis, obesity, hyperuricemia as well as its anti-cancer activities through adjusting multiple targets and multiple signals. Therefore, dioscin is a promising multi-target candidate to treat various diseases. This review paper summarized the progress on pharmacological activities and mechanisms of dioscin, which may provide useful data for development and exploration of this natural product in the further.

Keywords: Cancer; Diabetes; Dioscin; Metabolic disorder; Obesity; Osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Diosgenin / analogs & derivatives*
  • Diosgenin / therapeutic use
  • Humans
  • Metabolic Diseases / drug therapy*
  • Neoplasms / drug therapy*

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • dioscin
  • Diosgenin